Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02411461 · ClinicalTrials.gov registry record
Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 39
- Enrollment target
NCT02411461: Completed study, sponsored by Vanderbilt University Medical Center.
NCT02411461 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02411461 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
Pseudohypoparathyroidism type 1a (PHP1a) is a rare disease that causes childhood obesity and learning difficulties. This study will investigate eating behaviors and perform cognitive testing on children with PHP1a. The investigators will compare their results to those of healthy siblings and other obese children.
Primary Outcome
Intelligence quotient as measured by Kaufman Brief Intelligence Test, 2nd Edition. This scale yields standard scores where the mean is 100 and one standard deviation is 15. Higher scores indicate better function.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2014-12-01 |
| Est. Completion | 2017-01 |
What the finished NCT02411461 record still lists
NCT02411461 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02411461 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02411461 about?
NCT02411461 is a clinical study titled "Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism". Pseudohypoparathyroidism type 1a (PHP1a) is a rare disease that causes childhood obesity and learning difficulties. This study will investigate eating behaviors and perform cognitive testing on children with PHP1a. The investigators will compare their results to those of healthy siblings and other o...
What is the current status of trial NCT02411461?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2014-12-01. Estimated completion is 2017-01.
Who is sponsoring clinical trial NCT02411461?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI